lncRNA HULC linked to phenylketonuria prevention, HULC-mimetics show therapeutic promise Aug. 13, 2021
Preclinical data confirm survival benefit of adding Veyonda to LuPSMA in prostate cancer Aug. 13, 2021
ON-108600 leads to potent tumor growth inhibition in chemotherapy-resistant TNBC models Aug. 13, 2021
RSS